Journal
Heliyon
Publication Date
12-1-2022
Volume
8
Issue
12
First Page
e12450
Document Type
Open Access Publication
DOI
10.1016/j.heliyon.2022.e12450
Rights and Permissions
Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec 19;8(12):e12450. doi: 10.1016/j.heliyon.2022.e12450. © 2022 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Abdelbaki, Mohamed S; DeWire Schottmiller, Mariko Dawn; Cripe, Timothy P; Curry, Richard C; Cruze, Charles A; Her, Leah; Demko, Suzanne; Casey, Denise; and Setty, Bhuvana, "An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors." Heliyon. 8, 12. e12450 (2022).
https://digitalcommons.wustl.edu/oa_4/2511
